Advancing Biosafety Testing of Biotherapeutics with droplet digital PCR Technology
Dr Edmund Ang is currently a Principal Scientist with MERCK BioReliance® Biosafety Testing Services providing scientific and technical support and thought leadership on biologics safety testing to biopharma in the Asia Pacific region. He has extensive life science research and development experiences from both academic and industrial settings. He obtained his PhD in Cell Biology from the University of Edinburgh, Scotland, UK, followed by postdoctoral research on cell signalling at Stanford University, California, USA, and at the National Cancer Centre Singapore, before joining Ionis Pharmaceuticals and Eli Lilly working on cancer drug and biomarker discovery programs. He also has commercial experience with biotech companies including Roche Diagnostics and Thermo Fisher Scientific in the areas of cellular analysis, applied markets and bioproduction.
About the speaker:
Dr Edmund Ang
Principal Scientist, Field Development Services, Asia Pacific, MERCK BioReliance® Biosafety Testing Services, Singapore
Get Access to this Webinar
Share a little information with us to access this webinar.
Required fields